These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19156022)

  • 1. Intrathecal ziconotide and baclofen provide pain relief in seven patients with neuropathic pain and spasticity: case reports.
    Saulino M; Burton AW; Danyo DA; Frost S; Glanzer J; Solanki DR
    Eur J Phys Rehabil Med; 2009 Mar; 45(1):61-7. PubMed ID: 19156022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose Intrathecal Ziconotide for Spasticity From Primary Lateral Sclerosis: A Case Report.
    Zhu X; Kohan LR; Goldstein RB
    A A Pract; 2019 Jul; 13(1):31-33. PubMed ID: 31260413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
    Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M
    Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain.
    Wallace MS; Kosek PS; Staats P; Fisher R; Schultz DM; Leong M
    Pain Med; 2008 Apr; 9(3):271-81. PubMed ID: 18366507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study.
    Deer TR; Kim C; Bowman R; Tolentino D; Stewart C; Tolentino W
    Pain Physician; 2009; 12(4):E291-6. PubMed ID: 19668287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous intrathecal baclofen administration by a fully implantable electronic pump for severe spasticity treatment: our experience.
    Guglielmino A; Sorbello M; Fazzio S; Zingale SF; Bucolo GE; Pittalà G; Castiglione A; Patti F; Mangiameli S
    Minerva Anestesiol; 2006 Oct; 72(10):807-20. PubMed ID: 17006418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.
    Staats PS; Yearwood T; Charapata SG; Presley RW; Wallace MS; Byas-Smith M; Fisher R; Bryce DA; Mangieri EA; Luther RR; Mayo M; McGuire D; Ellis D
    JAMA; 2004 Jan; 291(1):63-70. PubMed ID: 14709577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does pain relief influence recovery of consciousness? A case report of a patient treated with ziconotide.
    Lanzillo B; Loreto V; Calabrese C; Estraneo A; Moretta P; Trojano L
    Eur J Phys Rehabil Med; 2016 Apr; 52(2):263-6. PubMed ID: 25491316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain.
    Wermeling DP; Berger JR
    Pharmacotherapy; 2006 Mar; 26(3):395-402. PubMed ID: 16503720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous treatment of intractable pain and spasticity: observations of combined intrathecal baclofen-morphine therapy over a 10-year clinical experience.
    Saulino M
    Eur J Phys Rehabil Med; 2012 Mar; 48(1):39-45. PubMed ID: 21525824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal baclofen for muscle spasticity and pain--two case reports.
    Al Khudhairi D; Rababa A; Saddiqui MN
    Middle East J Anaesthesiol; 2006 Jun; 18(5):971-6. PubMed ID: 17094537
    [No Abstract]   [Full Text] [Related]  

  • 12. Ziconotide combination intrathecal therapy: rationale and evidence.
    Wallace MS; Rauck RL; Deer T
    Clin J Pain; 2010 Sep; 26(7):635-44. PubMed ID: 20639730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal ziconotide for neuropathic pain: a review.
    Rauck RL; Wallace MS; Burton AW; Kapural L; North JM
    Pain Pract; 2009; 9(5):327-37. PubMed ID: 19682321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives.
    Natale M; Mirone G; Rotondo M; Moraci A
    Clin Neurol Neurosurg; 2012 May; 114(4):321-5. PubMed ID: 22104692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of intrathecal ziconotide in chronic pain patients.
    Wermeling D; Drass M; Ellis D; Mayo M; McGuire D; O'Connell D; Hale V; Chao S
    J Clin Pharmacol; 2003 Jun; 43(6):624-36. PubMed ID: 12817525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined intrathecal baclofen and morphine infusion for the treatment of spasticity related pain and central deafferentiation pain.
    Gatscher S; Becker R; Uhle E; Bertalanffy H
    Acta Neurochir Suppl; 2002; 79():75-6. PubMed ID: 11974992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ziconotide intrathecal delivery as treatment for secondary therapeutic failure of motor cortex stimulation after 6 years.
    Voirin J; Darie I; Fischer D; Simon A; Rohmer-Heitz I; Proust F
    Neurochirurgie; 2016 Oct; 62(5):284-288. PubMed ID: 27771111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.
    Rekand T; Grønning M
    J Rehabil Med; 2011 May; 43(6):511-4. PubMed ID: 21533331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziconotide for the treatment of severe spasticity after spinal cord injury.
    Ridgeway B; Wallace M; Gerayli A
    Pain; 2000 Mar; 85(1-2):287-9. PubMed ID: 10692630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.